RecruitingPhase 1NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Sponsor: Eli Lilly and Company
Salt Lake City, UT · West Valley City, UT · +21 more sites
Lung Cancer clinical trials in Salt Lake City, UT
24 recruiting lung cancer studies with a site in Salt Lake City, UT.
RecruitingPhase 1 / Phase 2NCT06810544
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Sponsor: Tango Therapeutics, Inc.
Salt Lake City, UT · +14 more sites
RecruitingPhase 2 / Phase 3NCT06712316
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)
Sponsor: BioNTech SE
Salt Lake City, UT · +52 more sites
RecruitingPhase 1 / Phase 2NCT07020221
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Sponsor: Verastem, Inc.
Salt Lake City, UT · +12 more sites
RecruitingPhase 2NCT06031688
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Sponsor: SWOG Cancer Research Network
Salt Lake City, UT · +277 more sites
RecruitingPhase 3NCT07222566
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Sponsor: Pfizer
Salt Lake City, UT · +225 more sites
RecruitingPhase not listedNCT07460440
SPARC - Screening for Lung Cancer With Platelets Via an AI-enabled RNA-based Classifier
Sponsor: University of Utah
Salt Lake City, UT
RecruitingPhase 3NCT06561386
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Sponsor: Bristol-Myers Squibb
Salt Lake City, UT · +55 more sites
RecruitingPhase 2 / Phase 3NCT07063745
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
Sponsor: Bristol-Myers Squibb
Salt Lake City, UT · +43 more sites
RecruitingPhase 3NCT06767514
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Sponsor: Summit Therapeutics
Salt Lake City, UT · +96 more sites
RecruitingPhase 1NCT07020117
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
Sponsor: Aktis Oncology, Inc.
Salt Lake City, UT · +13 more sites
RecruitingPhase not listedNCT05059444
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Sponsor: Guardant Health, Inc.
Salt Lake City, UT · +32 more sites
RecruitingPhase 1 / Phase 2NCT06043817
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
Sponsor: Pierre Fabre Medicament
Salt Lake City, UT · +8 more sites
RecruitingPhase 1NCT06586515
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Sponsor: Eli Lilly and Company
Salt Lake City, UT · +24 more sites
RecruitingNot applicableNCT07716280
Digital Health Implementation Strategies to Improve Lung Cancer Screening Among Safety-Net Clinics
Sponsor: University of Utah
Salt Lake City, UT
RecruitingPhase 2NCT05642572
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Sponsor: SWOG Cancer Research Network
Salt Lake City, UT · +453 more sites
RecruitingPhase 1NCT06917079
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Salt Lake City, UT · +15 more sites
RecruitingPhase 2 / Phase 3NCT03851445
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Sponsor: SWOG Cancer Research Network
American Fork, UT · Cedar City, UT · Logan, UT · +1226 more sites
RecruitingPhase 1 / Phase 2NCT05379985
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Sponsor: Revolution Medicines, Inc.
Salt Lake City, UT · +20 more sites
RecruitingPhase not listedNCT06934343
Machine Learning Approaches to Personalized Therapy for Advanced Non-small Cell Lung Cancer With Real-World Data
Sponsor: University of Utah
Salt Lake City, UT
RecruitingPhase 3NCT02468024
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
Sponsor: University of Texas Southwestern Medical Center
Salt Lake City, UT · +39 more sites
RecruitingNot applicableNCT06945484
PILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study
Sponsor: University of Utah
Salt Lake City, UT · +1 more sites
RecruitingPhase 1 / Phase 2NCT05490472
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
Sponsor: Jacobio Pharmaceuticals Co., Ltd.
Salt Lake City, UT · +3 more sites
Not yet recruitingNot applicableNCT07599943
Population Health Management -Increase Lung Cancer Screening in Community Health Centers (LungSMART)
Sponsor: University of Utah
Salt Lake City, UT
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.